EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Lymphocytic colitis can be transcriptionally divided into channelopathic and inflammatory lymphocytic colitis

Archana Bhardwaj, Andreas Münch iD, Julia Montague, Stefan Koch iD, Philip Rosenstiel iD, Celia Escudero-Hernández iD

United European Gastroenterology Journal · 2024-07 · 12 (6) · 737-748

DOI: 10.1002/ueg2.12531 ↗

Kurz gefasst

Fachartikel in der Zeitschrift United European Gastroenterology Journal, online erschienen am 17.02.2024. Verfasst von Archana Bhardwaj und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Clinical Molecular Biology (IKMB), Christian-Albrechts-University and University Hospital Schleswig-Holstein, Kiel, Germany. Hauptthemen laut MEDLINE: Colitis, Lymphocytic, Intestinal Mucosa. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Knut och Alice Wallenbergs Stiftelse, Deutsche Forschungsgemeinschaft, Ferring.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The pathobiology of the non‐destructive inflammatory bowel disease (IBD) lymphocytic colitis (LC) is poorly understood. We aimed to define an LC‐specific mucosal transcriptome to gain insight into LC pathology, identify unique genomic signatures, and uncover potentially druggable disease pathways.

Methods

We performed bulk RNA‐sequencing of LC and collagenous colitis (CC) colonic mucosa from patients with active disease, and healthy controls ( n = 4–10 per cohort). Differential gene expression was analyzed by gene‐set enrichment and deconvolution analyses to identify pathologically relevant pathways and cells, respectively, altered in LC. Key findings were validated using reverse transcription quantitative PCR and/or immunohistochemistry. Finally, we compared our data with a previous cohort of ulcerative colitis and Crohn's disease patients ( n = 4 per group) to distinguish non‐destructive from classic IBD.

Results

LC can be subdivided into channelopathic LC, which is governed by organic acid and ion transport dysregulation, and inflammatory LC, which is driven by microbial immune responses. Inflammatory LC displays an innate and adaptive immunity that is limited compared to CC and classic IBD. Conversely, we noted a distinct induction of regulatory non‐coding RNA species in inflammatory LC samples. Moreover, compared with CC, water channel and cell adhesion molecule gene expression decreased in channelopathic LC, whereas it was accentuated in inflammatory LC and associated with reduced intestinal epithelial cell proliferation.

Conclusions

We conclude that LC can be subdivided into channelopathic LC and inflammatory LC that could be pathomechanistically distinct subtypes despite their shared clinical presentation. Inflammatory LC exhibits a dampened immune response compared to CC and classic IBDs. Our results point to regulatory micro‐RNAs as a potential disease‐specific feature that may be amenable to therapeutic intervention.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colitis, LymphocyticIntestinal MucosaHumansTranscriptomeFemaleColitis, CollagenousCrohn DiseaseMaleColonMiddle AgedCase-Control StudiesGene Expression ProfilingColitis, UlcerativeAdult

Stichwörter der Autor:innen

RNA sequencingchannelopathic lymphocytic colitislymphocytic colitismicroscopic colitis

Autor:innen und Institutionen

  • Institute of Clinical Molecular Biology (IKMB), Christian-Albrechts-University and University Hospital Schleswig-Holstein, Kiel, Germany.
  • Department of Biomedical and Clinical Sciences (BKV), Linköping University, Linköping, Sweden.
  • Department of Gastroenterology and Hepatology, Linköping University, Linköping, Sweden.
  • Department of Health, Medicine, and Caring Sciences, Linköping University, Linköping, Sweden.
  • Wallenberg Centre for Molecular Medicine (WCMM), Linköping University, Linköping, Sweden.

ORCID-Profile: Andreas Münch, Stefan Koch, Philip Rosenstiel, Celia Escudero-Hernández

Förderung

  • Knut och Alice Wallenbergs Stiftelse
  • Deutsche Forschungsgemeinschaft
  • Ferring
  • Region Östergötland

Zitieren

APA

Bhardwaj, A., Münch, A., Montague, J., Koch, S., Rosenstiel, P., & Escudero-Hernández, C. (2024). Lymphocytic colitis can be transcriptionally divided into channelopathic and inflammatory lymphocytic colitis. United European Gastroenterology Journal, 12(6), 737-748. https://doi.org/10.1002/ueg2.12531

Vancouver

Bhardwaj A, Münch A, Montague J, Koch S, Rosenstiel P, Escudero-Hernández C. Lymphocytic colitis can be transcriptionally divided into channelopathic and inflammatory lymphocytic colitis. United European Gastroenterology Journal. 2024;12(6):737-748. doi:10.1002/ueg2.12531

BibTeX
@article{Bhardwaj2024,
  author = {Bhardwaj, Archana and Münch, Andreas and Montague, Julia and Koch, Stefan and Rosenstiel, Philip and Escudero-Hernández, Celia},
  title = {Lymphocytic colitis can be transcriptionally divided into channelopathic and inflammatory lymphocytic colitis},
  journal = {United European Gastroenterology Journal},
  year = {2024},
  volume = {12},
  number = {6},
  pages = {737--748},
  doi = {10.1002/ueg2.12531}
}
Kostenlos starten →